The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo

Overview of attention for article published in Molecular Cancer Therapeutics, November 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 2 patents

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 74 Dimensions

Readers on

mendeley: 84 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

HDR ENHANCERS

Application WO-2021234388-A1

World Intellectual Property Organisation (WIPO)

Pharmaceutically active compounds

Grant US-9447092-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.